Skip to Content

Efinaconazole topical Pregnancy and Breastfeeding Warnings

Efinaconazole topical is also known as: Jublia

Medically reviewed on November 13, 2017.

Efinaconazole topical Pregnancy Warnings

Animal studies have revealed evidence of embryofetal toxicity at subcutaneous doses that produced maternal toxicity. There are no controlled data in human pregnancy.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus.

US FDA pregnancy category: C

See references

Efinaconazole topical Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Yes (after subcutaneous doses)

Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Jublia (efinaconazole topical)." Valeant Pharmaceuticals, Costa Mesa, CA.

References for breastfeeding information

  1. "Product Information. Jublia (efinaconazole topical)." Valeant Pharmaceuticals, Costa Mesa, CA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide